1Sudoh T,Kangwa K,Minamion,et al.A new natriuretic peptide in porcine brain[J].Nature,1988,332 (6159):78-81.
2Troughton RW,Frampton CM,Yandle TG,et al.Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP)concentrations[J].Lancet,2000,355(9210):1126-1130.
3Marumoto K,Hamada M,Hiwada K.Increased secretion of atrial and brain natriuretic peptides during acute myocardial ischaemia induced by dynamic exercise in patients with angina pectoris[J].Clin Sci(Lond),1995,88 (5):551-556.
4Mukoyama M,Nakao K,Hosoda K,et al.Brain natriuretic peptide as a novel cardiac hormone in humans:evidence for an exquisite dual natriuretic peptide system,atrial natriuretic peptide and brain natriuretic peptide[J].J Clin Invest,1991,87 (4):1402-1412.
5Berger R,Huelsman M,Strecter K,et al.B-type natriuretic peptide predicts sudden death in patients with congestive heart failure[J].Circulation,2002,105 (20):2392-2397.
7Roth CG,Spottswood SE,Chan JC,et al.Evaluation of the hypertensive infant:a rational approach to diagnosis[J].Radiol Clin North Am,2003,141 (5):931-944.
9Humke U,Ziegler M.Renovascular arterial hypertension:current aspects of physiopathology,diagnosis,treatment[J].Ann Urol,1997,31 (2):64.
10Schoenberg SO,Knopp MV,Londy F,et al.Morphologic and functional magnetic resonance imaging of renal artery stenosis:a multireader tricenter study[J].J Am Soc Nephrol,2002,13(1):158-169.
二级参考文献13
1Mailloux LU, Napolitano B, Bellucci AG, et al. Renal vascular disease causing end-stage renal Ddsease, incidence, clinical correlates, and outcomes: a 20-year clinical experience. Am J Kidney Dis, 1994, 24: 622-629.
2O′Neil EA, Hansen KJ, Canzenello VJ, et al. Prevalence of ischemic nephropathy in patients with renal insufficiency. Am Surg, 1992, 58: 485-490.
3Wachtell K, Ibsen H, Olsen MH, et al. Prevalence of renal artery stenosis in patients with peripheral vascular disease and hypertension. J Hum Hypertens, 1996, 10:83-85.
4Olbricht CJ, Paul K, Prokop M, et al. Minimally invasive diagnosis of renal artery stenosis by spiral computed tomography angiography. Kidney Int, 1995,48:1332-1337.
5Prince MR, Schoenberg SO, Ward JS, et al. Hemodynamically significant atherosclerotic renal artery stenosis: MR angiographic features. Radiology, 1997, 205:128-136.
6Pedersen EB. New tools in diagnosing renal artery stenosis. Kidney Int, 2000, 57: 2657-2677.
7Oliva VL, Soulez G, Lesage D, et al. Detection of renal artery stenosis with Doppler sonography before and after administration of captopril: value of early systolic rise. AJR, 1998, 170: 169-175.
8Macleod M, Taylor AD, Baxter G, et al. Renal artery stenosis managed by palmaz stent insersion: technical and clinical outcome. J Hypertens, 1995, 13:1791-1795.
9Boisclair C, Therasse E, Oliver VL, et al. Treatment of renal angioplasty failure by percutaneous renal artery stenting with Palmaz stents: midterm technical and clinical results. AJR, 1997, 168: 245-251.
10Dorros G, Jaff M, Mathiak L, et al. Four-year follow-up Palmaz-Schatz stent revascularization as treatment for atherosclerotic renal artery stenosis. Circulation, 1998, 98:642-647.
